Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery

Schistosomiasis is a major endemic disease known for excessive mortality and morbidity in developing countries. Because praziquantel is the only drug available for its treatment, the risk of drug resistance emphasizes the need to discover new drugs for this disease. Cathepsin SmCL1 is the critical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafar, Atif, Ahmad, Sabahuddin, Rizvi, Asim, Ahmad, Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416924/
https://www.ncbi.nlm.nih.gov/pubmed/25933436
http://dx.doi.org/10.1371/journal.pone.0123996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416924/
https://www.ncbi.nlm.nih.gov/pubmed/25933436
http://dx.doi.org/10.1371/journal.pone.0123996

Ejemplares similares